SCHEMBL4329863

SCHEMBL4329863

O=C1OC=CC1Oc1ccc(Cl)cc1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.37
MAPT P10636 5/20 0.37
NR1I2 O75469 1/20 0.37
LMNA P02545 1/20 0.37
TTR P02766 1/20 0.37
PGR P06401 1/20 0.37
HSP90AA1 P07900 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
HSPA5 P11021 1/20 0.37
HPGD P15428 1/20 0.37
CBR1 P16152 1/20 0.37
TBXA2R P21731 1/20 0.37
SLC6A2 P23975 1/20 0.37
AGTR1 P30556 1/20 0.37
SLC6A3 Q01959 1/20 0.37
MRGPRX4 Q96LA9 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4329860 0.68 POLB (0.43) TDP1MAPTNR1I2LMNATTR
SCHEMBL11336642 0.66 TDP1 (0.47) TDP1MAPTNR1I2LMNATTR
SCHEMBL15171458 0.64 MAPT (0.41) TDP1MAPTMEN1KMT2ARXFP1
SCHEMBL27549924 0.63 TTR (0.52) TDP1MAPTNR1I2LMNATTR
SCHEMBL829749 0.62 TTR (0.56) TDP1MAPTNR1I2LMNATTR
SCHEMBL7186092 0.62 TTR (0.75) MAPTNR1I2LMNATTRPGR
SCHEMBL2297174 0.62 FPR2 (0.44) MAPTNR1I2LMNATTRPGR
SCHEMBL5372606 0.62 HTR2C (0.55) SLC6A2
SCHEMBL41991 0.62 TTR (0.50) TDP1MAPTNR1I2LMNATTR
Hydrochloric Acid SCHEMBL10276355 0.61 HTR2C (0.54) SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 TDP1 4437/4885MAPT 4654/4885NR1I2 158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.